Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
107,573,681
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
6,181,288
-
Shares change
-
-277,568
-
Total reported value, excl. options
-
$19,161,762
-
Value change
-
-$902,699
-
Put/Call ratio
-
311%
-
Number of buys
-
8
-
Number of sells
-
-22
-
Price
-
$3.1
Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q3 2021
48 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q3 2021.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,181,288 shares
of 107,573,681 outstanding shares and own 5.75% of the company stock.
Largest 10 shareholders include Lagoda Investment Management, L.P. (3,043,344 shares), MORGAN STANLEY (582,380 shares), BlackRock Inc. (537,351 shares), VANGUARD GROUP INC (511,758 shares), GEODE CAPITAL MANAGEMENT, LLC (270,820 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (266,100 shares), Ergoteles LLC (134,100 shares), RENAISSANCE TECHNOLOGIES LLC (128,700 shares), STATE STREET CORP (104,823 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (70,575 shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.